Cancer, Genomics And Consulting Ltd
13515820
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
30/06/2025
micro entity
Next accounts due
31/03/2027
Confirmation statement
Last: 15/07/2025
Due 29/07/2026
Industry
Officers
Persons with Significant Control
Dr Alexander Aresh Azizi
British · England · Age 35
Cart House 2, Copley Hill Business Park, Cambridge Road, Cambridge, CB22 3GN
Notified 16/07/2021
CompanyRankvs 32046+ SIC 62020 peers65
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/06/2025
Net Worth
£49k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
—
Working capital
Current Assets
£50k
Current Liabilities
£9k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 5.50 | -£5k |
| 2024 | 7.00 | +£39k |
| 2023 | 4.73 | — |
| 2022 | 1.08 | — |
Derived from filed accounts. Not audited figures.